BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Humana Calls Foul Play on Biogen’s Gaming of the System

  Biogen agreed to pay $22 million in response to allegations that it violated the False Claims Act, and now, life insurance company Humana is suing Biogen over a similar scheme.

  September 28, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Sputnik Vaccine Won’t Get Foreign Travelers into the US

  Sputnik Vaccine’s 91.6% efficacy against the original COVID-19 strain has stood up to peer review in The Lancet. But what’s the controversy, lets’s check it out.

  September 28, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Novel CAR T Therapies Help Celyad’s CMO Bring Hope to Fearful Patients

  Celyad is focusing on advancing chimeric antigen receptor T cell (CAR T) therapies.

  September 28, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  Lyme Disease Vaccine Moves to Phase III as Booster Trial Proves Effective

  The Phase II trial, VLA150202, evaluated the safety and immunogenicity of VLA15 on 246 healthy adults aged 18 to 65 years old across the United States.

  September 28, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Genetown

  MIT Spinout Raises $30 Million to Enable Next-Gen Engineered Cell Therapies

  Kytopen has seen an influx of cash of the past few months. Most recently, the biotech raised a large chunk of money in its Series A funding round, which was announced on Tuesday.

  September 28, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Students, Venture Capitalists Launch Equity-Free Program To Support Future Biotech Leaders

  Nucleate, the non-profit organization seeking to support future leaders in the life sciences industry, announced its official launch and immediately opened applications to its Activator program.

  September 28, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  FDA, CDC See Shift in Vaccines, Pandemic Response Leadership

  Peter Marks will serve as acting director of the Office of Vaccines Research and Review at the U.S. FDA following the resignation of two top officials at the agency.

  September 28, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  COVID-19 Vaccine Update: Data on Younger Children and mRNA Program Dropped

  Pfizer and BioNTech share data with FDA on COVID-19 vaccines for younger children as Sanofi pivot on its mRNA COVID-19 vaccine, shifting focus toward other infectious diseases instead.

  September 28, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  Anji Pharma Nets $70 Million to Bridge the Gap Between Patients and Medicines

  Anji will use the new funds to advance its two late-stage clinical programs in metabolic disorders and propel its oncology pipeline into the clinic.

  September 28, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  Avanir: Investing in Employees, Leading With Humanity and Integrity

  Avanir is developing its future leadership from within through a program it calls “Leading at Avanir,” which focuses on emotional intelligence and situational leadership components.

  September 28, 2021

   · 

  5 min read

   · 

  Heather McKenzie